Furthermore, it has been shown that LL-37 can act and expand OVA-antigen-specific CD8+ T cells in draining the lymph nodes and the tumor microenvironment (Mader et al., 2011a; Singh et al., 2012), which could potentially delay tumor growth. This evidence concerns the gene CD8A and neoplasm.